Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
Gaucher disease is a lysosomal storage disorder caused by insufficient glucocerebrosidase expression. Here, the authors describe a CRISPR/Cas9-based gene-editing approach to re-express this enzyme in human blood stem cells and show that they can engraft in NSG mice and differentiate into functional...
Guardado en:
Autores principales: | Samantha G. Scharenberg, Edina Poletto, Katherine L. Lucot, Pasqualina Colella, Adam Sheikali, Thomas J. Montine, Matthew H. Porteus, Natalia Gomez-Ospina |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/224d60d712dd4dc594a6f383d84a1ecd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Engineering monocyte/macrophage−specific glucocerebrosidase expression in human hematopoietic stem cells using genome editing
por: Samantha G. Scharenberg, et al.
Publicado: (2020) -
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
por: Natalia Gomez-Ospina, et al.
Publicado: (2019) -
Ocular phenotypes in a mouse model of impaired glucocerebrosidase activity
por: Martin Weber, et al.
Publicado: (2021) -
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins
por: Giulia Pavani, et al.
Publicado: (2020) -
Multivalent nanosystems: targeting monocytes/macrophages
por: Poupot R, et al.
Publicado: (2018)